Verve Therapeutics shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Verve Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Verve Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Verve Therapeutics by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $377k | 27k | 13.94 |
| 2023-09-30 | $359k | 27k | 13.26 |
| 2023-06-30 | $507k | 27k | 18.75 |
| 2023-03-31 | $356k | 25k | 14.42 |
| 2022-12-31 | $478k | 25k | 19.35 |
| 2022-09-30 | $848k | 25k | 34.35 |
| 2022-06-30 | $320k | 21k | 15.28 |
| 2022-03-31 | $478k | 21k | 22.83 |
| 2021-12-31 | $214k | 5.8k | 36.81 |
| 2021-09-30 | $273k | 5.8k | 47.00 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors